US2018207110A1PendingUtilityA1

Composition and method for inhibition of nerve transmission

Assignee: MCLELLAN ALEXANDERPriority: Feb 6, 2007Filed: Jan 19, 2018Published: Jul 26, 2018
Est. expiryFeb 6, 2027(~0.5 yrs left)· nominal 20-yr term from priority
A61K 31/122A61P 29/00A61K 31/351A61K 31/045A61K 31/22A61K 31/121A61P 25/04A61K 31/11A61P 25/00A61P 25/02A61K 36/185
50
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The presently claimed and disclosed invention(s) provides a therapeutically effective composition and method of inhibiting nerve cell transmission. In a preferred embodiment of the presently claimed and disclosed invention(s), the treatment of neuropathic pain utilizing terpene compounds isolated from plant essential oils or manufactured synthetically is detailed. These compounds, such as geraniol and citronellol, as well as chemical analogs thereof, used in combination or individually, can be used alone or in a composition with a pharmaceutically acceptable carrier in a suitable dosage form.

Claims

exact text as granted — not AI-modified
1 . A composition for the inhibition of nerve transmission comprising at least one terpene compound or a combination of terpene compounds and, optionally, one or more pharmaceutically acceptable diluent or excipient, wherein said terpene compound is selected from the group consisting of nerol, geraniol, neral, geranial, geranyl formate, geranyl butyrate, geranyl tiglate, citronellyl formate, neryl formate, isomenthone, citronellyl butyrate, citronellyl tiglate, menthone, rose oxide, and pharmaceutically acceptable isomers, salts, and esters thereof. 
     
     
         2 .- 25 . (canceled)

Join the waitlist — get patent alerts

Track US2018207110A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.